Company intelligence / Profile preview

HighCape Capital

Westport, Connecticut, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

HighCape Capital is a growth equity firm established in 2013 that invests in innovative, commercial-stage life sciences companies across biotechnology, medical devices, and healthcare, with a strong track record of supporting companies' transition from product development to commercialization through strategic investment and operational expertise.[1][2][4][9]

Industry: Investors

Partnerships

Baxter International

Beyond the preview

Go deeper on HighCape Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HighCape Capital.

Explore the full profile